FI783175A - IMIDAZOLE DERIVATIVES FOR SALTER DAERAV, DERAS SYNTES OCH MELLANPRODUKTER OCH PHARMACEUTICAL PREPARAT - Google Patents

IMIDAZOLE DERIVATIVES FOR SALTER DAERAV, DERAS SYNTES OCH MELLANPRODUKTER OCH PHARMACEUTICAL PREPARAT

Info

Publication number
FI783175A
FI783175A FI783175A FI783175A FI783175A FI 783175 A FI783175 A FI 783175A FI 783175 A FI783175 A FI 783175A FI 783175 A FI783175 A FI 783175A FI 783175 A FI783175 A FI 783175A
Authority
FI
Finland
Prior art keywords
och
syntes
deras
mellanprodukter
imidazole derivatives
Prior art date
Application number
FI783175A
Other languages
Finnish (fi)
Inventor
Peter Brian Thorogood
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI783175A publication Critical patent/FI783175A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI783175A 1977-10-19 1978-10-18 IMIDAZOLE DERIVATIVES FOR SALTER DAERAV, DERAS SYNTES OCH MELLANPRODUKTER OCH PHARMACEUTICAL PREPARAT FI783175A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB4353277 1977-10-19
GB4351277 1977-10-19
GB398478 1978-02-01

Publications (1)

Publication Number Publication Date
FI783175A true FI783175A (en) 1979-04-20

Family

ID=27254350

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783175A FI783175A (en) 1977-10-19 1978-10-18 IMIDAZOLE DERIVATIVES FOR SALTER DAERAV, DERAS SYNTES OCH MELLANPRODUKTER OCH PHARMACEUTICAL PREPARAT

Country Status (12)

Country Link
JP (1) JPS5488268A (en)
AT (1) AT370095B (en)
AU (1) AU522055B2 (en)
CA (1) CA1111433A (en)
DE (1) DE2845406A1 (en)
DK (1) DK464278A (en)
FI (1) FI783175A (en)
IE (1) IE47749B1 (en)
IL (1) IL55858A (en)
IT (1) IT1109321B (en)
MC (1) MC1221A1 (en)
ZA (1) ZA785863B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS6047257B2 (en) * 1979-07-19 1985-10-21 旭化成株式会社 Novel basic substances and their production methods
US4430445A (en) 1979-07-19 1984-02-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
GR78234B (en) * 1981-03-10 1984-09-26 Ciba Geigy Ag
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
ZA835967B (en) * 1982-08-14 1985-04-24 Wellcome Found Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
JPH01316365A (en) * 1988-03-24 1989-12-21 Shikoku Chem Corp 1-benzylimidazole compound, synthesis thereof and curing of polyepoxy resin using said compound

Also Published As

Publication number Publication date
CA1111433A (en) 1981-10-27
IL55858A (en) 1982-09-30
IE47749B1 (en) 1984-06-13
IL55858A0 (en) 1979-01-31
DE2845406A1 (en) 1979-05-03
IT1109321B (en) 1985-12-16
DK464278A (en) 1979-04-20
MC1221A1 (en) 1979-07-20
JPS6233227B2 (en) 1987-07-20
AU4082478A (en) 1980-04-24
AT370095B (en) 1983-02-25
JPS5488268A (en) 1979-07-13
AU522055B2 (en) 1982-05-13
ZA785863B (en) 1980-05-28
IE782067L (en) 1979-04-19
ATA747378A (en) 1982-07-15
IT7851570A0 (en) 1978-10-18

Similar Documents

Publication Publication Date Title
NL7809529A (en) IMIDAZOLE DERIVATIVES.
CU34980A (en) PROCEDURE FOR THE IMIDAZOLE DERIVATIVES FABRICATION
NO782768L (en) PROCEDURE FOR PREPARING ALKENDER DERIVATIVES
AR217888A1 (en) CROSS-HOLDER SUPPORT, PERFECTED
NL7802311A (en) SUBSTITUTED PHENOXYBENZYLOXYCARBONYL DERIVATIVES, METHODS FOR PREPARING THEM AND USE AS INSECTICIDES AND ACARICIDES.
IT7825315A0 (en) SUBSTITUTED PHENOXY-BENZYL-OXICARBONIL DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES AND AS ACARICIDES.
NL190519C (en) 4-Substituted phenylacetic acid compounds, as well as pharmaceutical preparations.
FI801229A (en) 4-AMINO-3-CARBOXY-ELLER CYANO-1,2-DIHYDRO-2-OXO-1,8-NAPHTHYRIDE DERIVATIVES
NO813208L (en) PROCEDURE FOR PREPARING 3-ARYL-5-ISOTIAZOLE DERIVATIVES.
PT67641B (en) PROCESS FOR PREPARING PYRROLIDINIC DERIVATIVES
FI783751A (en) PEPTIDER, DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE THERAPEUTIC BLANDNINGAR
SE7808059L (en) PROCEDURE FOR PREPARING 1,2,4-TRIAZIN-5-ON DERIVATIVES
FI783033A (en) PROCEDURE FOR FRAMSTATING AV 4,5-DIHYDRO-2-ALCOXY-CARBONYLAMINO-5-CARBOCYCLISK-ARYL-IMIDATSOLER OR DERIVATIVES
DD135346A5 (en) Imidazole derivatives
NO152220C (en) PROCEDURE FOR PREPARING SESQUITER PENDING DERIVATIVES
FI783175A (en) IMIDAZOLE DERIVATIVES FOR SALTER DAERAV, DERAS SYNTES OCH MELLANPRODUKTER OCH PHARMACEUTICAL PREPARAT
NO146059C (en) PHENYLISOTIOCYANATE DERIVATIVES FOR USE AS FUNGICIDES
NO147437C (en) PARTICULAR SUBSTANCE FOR DRUGS.
FI783223A (en) PYRAZINOBENSOXATSEPINDERIVAT, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DESAMMA INNEHAOLLANDE PHARMACEUTICAL BLANDNINGAR
NL7608915A (en) IGNITION-PROTECTIVE IMIDAZOLE DERIVATIVES.
MC1192A1 (en) BENZIMIDAZOLE DERIVATIVES
IT7821719A0 (en) PROCEDURE FOR PREPARING 4-HYDROXY-5-ALKYL- AND 4-HYDROXY-2,5-DIALKYL-3-OXO-2H-FU RANI.
NO147423C (en) PROCEDURE FOR PREPARING 2-PIPERAZINYL-CHINAZOLINE DERIVATIVES.
NL7804907A (en) NEW CHROMEEN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC PREPARATIONS.
NO149471C (en) ANALOGY PROCEDURE FOR PREPARING PHARMASOYYTIC ACTIVE TETRACYCLONON DERIVATIVES

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE WELLCOME FOUNDATION, LIMITED